Form 4 Filing for Evogene Ltd.

This filing is a Form 4 for Evogene Ltd., reporting on transactions by Leon Recanati, a director. On September 4, 2026, 2,500 stock options were granted with an exercise price of $0.58 per share. These options vest quarterly starting September 4, 2026, and will be fully vested by September 4, 2027. The filing also notes that Mr. Recanati directly owns 1,343,886 ordinary shares following these transactions. The filing includes a power of attorney document authorizing Nitsan Deutsch to execute these filings on behalf of Mr. Recanati.